Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.

Saved in:
Bibliographic Details
Title: Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.
Authors: Nemunaitis J; Physician Reliance Network, Inc., and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas 75246, USA., Bohart C, Fong T, Meyer W, Edelman G, Paulson RS, Orr D, Jain V, O'Brien J, Kuhn J, Kowal KJ, Burkeholder S, Bruce J, Ognoskie N, Wynne D, Martineau D, Ando D
Source: Cancer gene therapy [Cancer Gene Ther] 1998 Sep-Oct; Vol. 5 (5), pp. 292-300.
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print Cited Medium: Print ISSN: 0929-1903 (Print) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 9824048
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nemunaitis+J%22">Nemunaitis J</searchLink>; Physician Reliance Network, Inc., and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas 75246, USA.<br /><searchLink fieldCode="AU" term="%22Bohart+C%22">Bohart C</searchLink><br /><searchLink fieldCode="AU" term="%22Fong+T%22">Fong T</searchLink><br /><searchLink fieldCode="AU" term="%22Meyer+W%22">Meyer W</searchLink><br /><searchLink fieldCode="AU" term="%22Edelman+G%22">Edelman G</searchLink><br /><searchLink fieldCode="AU" term="%22Paulson+RS%22">Paulson RS</searchLink><br /><searchLink fieldCode="AU" term="%22Orr+D%22">Orr D</searchLink><br /><searchLink fieldCode="AU" term="%22Jain+V%22">Jain V</searchLink><br /><searchLink fieldCode="AU" term="%22O'Brien+J%22">O'Brien J</searchLink><br /><searchLink fieldCode="AU" term="%22Kuhn+J%22">Kuhn J</searchLink><br /><searchLink fieldCode="AU" term="%22Kowal+KJ%22">Kowal KJ</searchLink><br /><searchLink fieldCode="AU" term="%22Burkeholder+S%22">Burkeholder S</searchLink><br /><searchLink fieldCode="AU" term="%22Bruce+J%22">Bruce J</searchLink><br /><searchLink fieldCode="AU" term="%22Ognoskie+N%22">Ognoskie N</searchLink><br /><searchLink fieldCode="AU" term="%22Wynne+D%22">Wynne D</searchLink><br /><searchLink fieldCode="AU" term="%22Martineau+D%22">Martineau D</searchLink><br /><searchLink fieldCode="AU" term="%22Ando+D%22">Ando D</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229432230%22">Cancer gene therapy</searchLink> [Cancer Gene Ther] 1998 Sep-Oct; Vol. 5 (5), pp. 292-300.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Clinical Trial, Phase I; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9432230 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0929-1903 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209291903%22">09291903 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Gene Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=9824048
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 292
    Titles:
      – TitleFull: Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nemunaitis J
      – PersonEntity:
          Name:
            NameFull: Bohart C
      – PersonEntity:
          Name:
            NameFull: Fong T
      – PersonEntity:
          Name:
            NameFull: Meyer W
      – PersonEntity:
          Name:
            NameFull: Edelman G
      – PersonEntity:
          Name:
            NameFull: Paulson RS
      – PersonEntity:
          Name:
            NameFull: Orr D
      – PersonEntity:
          Name:
            NameFull: Jain V
      – PersonEntity:
          Name:
            NameFull: O'Brien J
      – PersonEntity:
          Name:
            NameFull: Kuhn J
      – PersonEntity:
          Name:
            NameFull: Kowal KJ
      – PersonEntity:
          Name:
            NameFull: Burkeholder S
      – PersonEntity:
          Name:
            NameFull: Bruce J
      – PersonEntity:
          Name:
            NameFull: Ognoskie N
      – PersonEntity:
          Name:
            NameFull: Wynne D
      – PersonEntity:
          Name:
            NameFull: Martineau D
      – PersonEntity:
          Name:
            NameFull: Ando D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 1998 Sep-Oct
              Type: published
              Y: 1998
          Identifiers:
            – Type: issn-print
              Value: 0929-1903
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Cancer gene therapy
              Type: main
ResultId 1